Ganglberger E, Grunberger K, Sponer B, Radauer C, Breiteneder H, Boltz-Nitulescu G, Scheiner O, Jensen-Jarolim E
Department of Pathophysiology, AKH, Medical School, University of Vienna, A-1090 Vienna, Austria.
FASEB J. 2000 Nov;14(14):2177-84. doi: 10.1096/fj.99-1000com.
There is no definite information available on the structural characteristics of IgE binding epitopes on allergenic molecules, although it is widely accepted that most of them are conformational. In the current study we aimed to characterize the IgE epitope of Bet v 1, the major birch pollen allergen, by the application of phage display peptide libraries. We purified IgE specific for Bet v 1 from allergic patients' sera to select mimotopes representing artificial IgE epitopes by biopanning of phage libraries. By linear alignment, it was not possible to attribute mimotope sequences to the primary structure of Bet v 1. We developed a computer-aided, 3-dimensional coarse-grained epitope search. The 3-dimensional search, followed by statistical analysis, revealed an exposed area on the Bet v 1 molecule (located between residues 9-22 and 104-123) as the IgE binding structure. The IgE epitope was located at a 30 A distance from a previously described IgG epitope and the respective mimotope, designated Bet mim E. Such mimotopes could potentially be used for the induction of IgG capable of interfering with the IgE/allergen interaction. To test this hypothesis, we immunized BALB/c mice with the phage-displayed Bet mim E. Immunizations resulted in the induction of Bet v 1-specific IgG, which was able to block the IgE binding to Bet v 1 in vitro. Based on these observations, we propose that immunotherapy with IgE mimotopes generated by biopannings result in formation of blocking IgG. We conclude that mimotope immunotherapy may represent a new and promising concept for treatment of type I allergic disease.
尽管人们普遍认为变应原分子上的大多数IgE结合表位是构象性的,但目前尚无关于其结构特征的确切信息。在本研究中,我们旨在通过应用噬菌体展示肽库来表征主要桦树花粉变应原Bet v 1的IgE表位。我们从过敏患者血清中纯化出对Bet v 1特异的IgE,通过噬菌体库的生物淘选来选择代表人工IgE表位的模拟表位。通过线性比对,无法将模拟表位序列与Bet v 1的一级结构相关联。我们开发了一种计算机辅助的三维粗粒度表位搜索方法。三维搜索并经统计分析后,揭示了Bet v 1分子上一个暴露区域(位于第9 - 22位氨基酸残基与第104 - 123位氨基酸残基之间)为IgE结合结构。该IgE表位与先前描述的IgG表位及相应的模拟表位(命名为Bet mim E)相距30 Å。这种模拟表位可能潜在地用于诱导能够干扰IgE/变应原相互作用的IgG。为验证这一假设,我们用噬菌体展示的Bet mim E免疫BALB/c小鼠。免疫诱导产生了Bet v 1特异的IgG,其能够在体外阻断IgE与Bet v 1的结合。基于这些观察结果,我们提出通过生物淘选产生的IgE模拟表位进行免疫治疗可导致产生阻断性IgG。我们得出结论,模拟表位免疫治疗可能代表了一种治疗I型变态反应性疾病的新的且有前景的概念。